NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers
Nkarta, Inc.
Nkarta, Inc.
Verismo Therapeutics
ModeX Therapeutics, An OPKO Health Company
Poseida Therapeutics, Inc.
LTZ Therapeutics, Inc.
Chengdu Zenitar Biomedical Technology Co., Ltd
Eli Lilly and Company